Vaccine Effectiveness Against Pediatric Influenza-A–Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022–2023 Season: VISION Network
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciad704 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Katherine Adams und 28 weiteren Autor:innen. Beteiligte Einrichtung: Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, Kaiser Foundation Hospitals.
Abstract (Originalsprache)
Background
During the 2022–2023 influenza season, the United States experienced the highest influenza-associated pediatric hospitalization rate since 2010–2011. Influenza A/H3N2 infections were predominant.
Methods
We analyzed acute respiratory illness (ARI)–associated emergency department or urgent care (ED/UC) encounters or hospitalizations at 3 health systems among children and adolescents aged 6 months–17 years who had influenza molecular testing during October 2022–March 2023. We estimated influenza A vaccine effectiveness (VE) using a test-negative approach. The odds of vaccination among influenza-A–positive cases and influenza-negative controls were compared after adjusting for confounders and applying inverse-propensity-to-be-vaccinated weights. We developed overall and age-stratified VE models.
Results
Overall, 13 547 of 44 787 (30.2%) eligible ED/UC encounters and 263 of 1862 (14.1%) hospitalizations were influenza-A–positive cases. Among ED/UC patients, 15.2% of influenza-positive versus 27.1% of influenza-negative patients were vaccinated; VE was 48% (95% confidence interval [CI], 44–52%) overall, 53% (95% CI, 47–58%) among children aged 6 months–4 years, and 38% (95% CI, 30–45%) among those aged 9–17 years. Among hospitalizations, 17.5% of influenza-positive versus 33.4% of influenza-negative patients were vaccinated; VE was 40% (95% CI, 6–61%) overall, 56% (95% CI, 23–75%) among children ages 6 months–4 years, and 46% (95% CI, 2–70%) among those 5–17 years.
Conclusions
During the 2022–2023 influenza season, vaccination reduced the risk of influenza-associated ED/UC encounters and hospitalizations by almost half (overall VE, 40–48%). Influenza vaccination is a critical tool to prevent moderate-to-severe influenza illness in children and adolescents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Department of Clinical Research, Westat, Rockville, Maryland, USA.
- Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, California, USA.
- Department of Research, HealthPartners Institute, Minneapolis, Minnesota, USA.
- Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA.
- Department of Science Programs, Kaiser Permanente Center for Health Research, Portland, Oregon, USA.
ORCID-Profile: Katherine Adams, Suchitra Rao, Manjusha Gaglani, Karthik Natarajan, Ousseny Zerbo, Mark W Tenforde
Förderung
- Intramural CDC HHS
- Kaiser Foundation Hospitals
Zitieren
APA
Adams, K., Weber, Z. A., Yang, D. H., Klein, N. P., DeSilva, M. B., Dascomb, K., Irving, S. A., Naleway, A. L., Rao, S., Gaglani, M., Flannery, B., Garg, S., Kharbanda, A. B., Grannis, S. J., Ong, T. C., Embi, P. J., Natarajan, K., Fireman, B., Zerbo, O., …, & Tenforde, M. W. (2024). Vaccine Effectiveness Against Pediatric Influenza-A–Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022–2023 Season: VISION Network. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad704
Vancouver
Adams K, Weber ZA, Yang DH, Klein NP, DeSilva MB, Dascomb K, et al. Vaccine Effectiveness Against Pediatric Influenza-A–Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022–2023 Season: VISION Network. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciad704
BibTeX
@article{Adams2024,
author = {Adams, Katherine and Weber, Zachary A and Yang, Duck-Hye and Klein, Nicola P and DeSilva, Malini B and Dascomb, Kristin and Irving, Stephanie A and Naleway, Allison L and Rao, Suchitra and Gaglani, Manjusha and Flannery, Brendan and Garg, Shikha and Kharbanda, Anupam B and Grannis, Shaun J and Ong, Toan C and Embi, Peter J and Natarajan, Karthik and Fireman, Bruce and Zerbo, Ousseny and Goddard, Kristin and Timbol, Julius and Hansen, John R and Grisel, Nancy and Arndorfer, Julie and Ball, Sarah W and Dunne, Margaret M and Kirshner, Lindsey and Chung, Jessie R and Tenforde, Mark W},
title = {Vaccine Effectiveness Against Pediatric Influenza-A–Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022–2023 Season: VISION Network},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciad704}
}
EUVIMED